Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
Explore this paper's citation graph
Summary
The guidelines about febrile neutropenia in the setting of hematologic malignancies are reviewed, providing an overview of the definition of fever and neutropania, and categories of risk assessment, management of infections, and prophylaxis.
- Type
- review
- Published
- 2014-11-27
- Cited by
- 73
- References
- 72
- Access
- Open access
- OpenAlex
- https://openalex.org/W2013330239
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8380255
Keywords
Medicine, Neutropenia, Febrile neutropenia, Intensive care medicine, Hematologic Neoplasms
References
- Central and peripheral components of cardiac failure.
- Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
- Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
- Concept of empiric therapy with antibiotic combinations. Indications and limits.
- Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
- Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
- Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
- Hematological: Low all‐cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single‐center study
- Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
- Antibiotic prophylaxis in neutropenic patients
- Management of the febrile neutropenic cancer patient: lessons from 40 years of study.
- Use of antibacterial prophylaxis for patients with neutropenia
- The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
- Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
- Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
- I and i
- Fluoroquinolones
- Central Venous Catheter–Related Bacteremia Due to Gram-Negative Bacilli: Significance of Catheter Removal in Preventing Relapse
- Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
- Antifungal prophylaxis for severely neutropenic chemotherapy recipients
Cited by
- Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry
- Treatment of neutropenic fever in patients with malignancies
- Study of Common Bacterial and Fungal Pathogens in Children with Hematological Malignancies during Febrile Neutropenia: Single Center Egyptian Study.
- An Overview of Hematopoietic Stem Cell Transplantation
- Febrile Neutropenia in Cancer Patient: Epidemiology, Microbiology, Pathophysiology and Management
- Marijuana Smoking in Patients With Leukemia.
- Compatibility of Biosimilar Filgrastim with Cytotoxic Chemotherapy during the Treatment of Malignant Diseases (VENICE): A Prospective, Multicenter, Non-Interventional, Longitudinal Study
- Prospective study evaluating the incidence of bacteraemia and bacteruria in afebrile and febrile neutropaenic dogs undergoing chemotherapy
- Garenoxacin Prophylaxis for Febrile Neutropenia after Chemotherapy in Hematological Malignancies
- Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions
- Low rates of antibiotic resistance and infectious mortality in a cohort of high-risk hematology patients: A single center, retrospective analysis of blood stream infection
- Enterococcus spp. and S. aureus colonization in neutropenic febrile children with cancer.
- Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy
- A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia
- Pediatric Emergency Medicine: Chief Complaints and Differential Diagnosis
- Pseudomonas aeruginosa kao uzročnik infekcija kod hematoloških bolesnika
- Voriconazole in Prevention and Treatment of Febrile Neutropenia
- Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies
- Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses
- The Influence of Diabetes Mellitus on Glucuronidation and Sulphation of Paracetamol in Patients with Febrile Neutropenia
Related papers
- Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia
- Advances in the Treatment of Neutropenia
- Febrile neutropenia in patients with hematological malignancies - definition, diagnosis and management
- Phase I dose-escalation study of the investigational Aurora A kinase (AAK) inhibitor MLN8237 as an enteric-coated tablet (ECT) formulation in patients with nonhematologic malignancies.
- [Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia].
- Incidence of Febrile Neutropenia in Breast Cancer Patients Treated With Chemotheraphy Protocols From 01.01.2020 to 31.12.2021 in University Clinical Center of Republic of Srpska Banja Luka
- Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy
- Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
- P298 Febrile neutropenia (FN) in patients with hematologic malignancy: a Canadian multi-center observational study